339 related articles for article (PubMed ID: 30968825)
21. Seroprevalence study of HCV among hospitalized intravenous drug users in Ahvaz, Iran (2001-2006).
Alavi SM; Alavi L
J Infect Public Health; 2009; 2(1):47-51. PubMed ID: 20701860
[TBL] [Abstract][Full Text] [Related]
22. A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.
Removille N; Origer A; Couffignal S; Vaillant M; Schmit JC; Lair ML
BMC Public Health; 2011 May; 11():351. PubMed ID: 21595969
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of antibodies to human immunodeficiency virus (HIV), hepatitis B and hepatitis C and risk factors in prisoners in Lebanon.
Mahfoud Z; Kassak K; Kreidieh K; Shamra S; Ramia S
J Infect Dev Ctries; 2010 Mar; 4(3):144-9. PubMed ID: 20351454
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and correlates of HCV, HVB, and HIV infection among prison inmates and staff, Hungary.
Tresó B; Barcsay E; Tarján A; Horváth G; Dencs A; Hettmann A; Csépai MM; Gyori Z; Rusvai E; Takács M
J Urban Health; 2012 Feb; 89(1):108-16. PubMed ID: 22143408
[TBL] [Abstract][Full Text] [Related]
25. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.
Lehmann M; Meyer MF; Monazahian M; Tillmann HL; Manns MP; Wedemeyer H
J Med Virol; 2004 Jul; 73(3):387-91. PubMed ID: 15170633
[TBL] [Abstract][Full Text] [Related]
26. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin.
Stark K; Bienzle U; Vonk R; Guggenmoos-Holzmann I
Int J Epidemiol; 1997 Dec; 26(6):1359-66. PubMed ID: 9447418
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C virus infection and its associated factors among prisoners in a Nigerian prison.
Okafor IM; Ugwu SO; Okoroiwu HU
BMC Gastroenterol; 2020 Oct; 20(1):360. PubMed ID: 33126856
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of and risk factors for HCV among incarcerated people at Great Tehran Prison: a cross-sectional study.
SeyedAlinaghi S; Farhoudi B; Shahmohamadi E; Rasoolinejad M; Hasannezhad M; Rashidi MR; Dadras O; Moradi A; Parmoon Z; Ebrahimi H; Asadollahi-Amin A
Int J Prison Health; 2023 Feb; ():. PubMed ID: 36757302
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B and hepatitis C virus infections and associated factors among prisoners in Gondar City, Northwest Ethiopia.
Tadesse K; Ayalew G; Million Y; Gelaw A
PLoS One; 2024; 19(4):e0301973. PubMed ID: 38626232
[TBL] [Abstract][Full Text] [Related]
30. Evaluating the Prevention Benefit of HCV Treatment: Modeling the SToP-C Treatment as Prevention Study in Prisons.
Lim AG; Stone J; Hajarizadeh B; Byrne M; Chambers GM; Martin NK; Grebely J; Dore GJ; Lloyd AR; Vickerman P
Hepatology; 2021 Nov; 74(5):2366-2379. PubMed ID: 34105797
[TBL] [Abstract][Full Text] [Related]
31. Tattooing in prison: a risk factor for HCV infection among inmates in the Quebec's provincial correctional system.
Poulin C; Courtemanche Y; Serhir B; Alary M
Ann Epidemiol; 2018 Apr; 28(4):231-235. PubMed ID: 29576049
[TBL] [Abstract][Full Text] [Related]
32. Differences in hepatitis C virus prevalence and clearance by mode of acquisition among men who have sex with men.
Seaberg EC; Witt MD; Jacobson LP; Detels R; Rinaldo CR; Young S; Phair JP; Thio CL
J Viral Hepat; 2014 Oct; 21(10):696-705. PubMed ID: 25280229
[TBL] [Abstract][Full Text] [Related]
33. Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia.
Prasetyo AA; Dirgahayu P; Sari Y; Hudiyono H; Kageyama S
J Infect Dev Ctries; 2013 Jun; 7(6):453-67. PubMed ID: 23771289
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis among prison inmates and officers at Nsawam and Accra, Ghana.
Adjei AA; Armah HB; Gbagbo F; Ampofo WK; Quaye IKE; Hesse IFA; Mensah G
J Med Microbiol; 2006 May; 55(Pt 5):593-597. PubMed ID: 16585647
[TBL] [Abstract][Full Text] [Related]
35. Seroprevalence of Hepatitis C Virus among Prisoners in Lakan Prison, North of Iran, Is There Still a Concern?
Mohtasham-Amiri Z; Rezvani SM; Ashoori F; Behboodi M; Toosi H; Jafari-Shakib R
Arch Iran Med; 2021 Oct; 24(10):765-770. PubMed ID: 34816699
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of Viremic hepatitis C, hepatitis B, and HIV infection, and vaccination status among prisoners in Stockholm County.
Gahrton C; Westman G; Lindahl K; Öhrn F; Dalgard O; Lidman C; Nilsson LH; Said K; Duberg AS; Aleman S
BMC Infect Dis; 2019 Nov; 19(1):955. PubMed ID: 31706284
[TBL] [Abstract][Full Text] [Related]
37. Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis.
Vescio MF; Longo B; Babudieri S; Starnini G; Carbonara S; Rezza G; Monarca R
J Epidemiol Community Health; 2008 Apr; 62(4):305-13. PubMed ID: 18339822
[TBL] [Abstract][Full Text] [Related]
38. Correlates of Hepatitis C Virus Infection in the Targeted Testing Program of the New York City Jail System.
Akiyama MJ; Kaba F; Rosner Z; Alper H; Kopolow A; Litwin AH; Venters H; MacDonald R
Public Health Rep; 2017; 132(1):41-47. PubMed ID: 28005477
[TBL] [Abstract][Full Text] [Related]
39. Incidence of hepatitis C infection among prisoners by routine laboratory values during a 20-year period.
Marco A; Gallego C; Caylà JA
PLoS One; 2014; 9(2):e90560. PubMed ID: 24587394
[TBL] [Abstract][Full Text] [Related]
40. Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners.
Crowley D; Murtagh R; Cullen W; Keevans M; Laird E; McHugh T; McKiernan S; Miggin SJ; O'Connor E; O'Reilly D; Betts-Symonds G; Tobin C; Van Hout MC; Lambert JS
Harm Reduct J; 2019 Jul; 16(1):42. PubMed ID: 31277665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
